BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 14727507)

  • 21. Pharmacogenomics - therapeutic and ethical issues.
    Patowary S
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomics in inflammatory bowel disease.
    Egan LJ; Derijks LJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):21-8. PubMed ID: 16431300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global genomic approaches to the iron-regulated proteome.
    Liu Y; Popovich Z; Templeton DM
    Ann Clin Lab Sci; 2005; 35(3):230-9. PubMed ID: 16081578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translating pharmacogenomics into personalized medicine and drug development.
    Zhang W; Chan TY; Fan L; Guo Y; Zhou HH
    Per Med; 2012 Jan; 9(1):93-97. PubMed ID: 29783288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of animal models in expression pharmacogenomic analyses.
    Rothberg BE
    Pharmacogenomics J; 2001; 1(1):48-58. PubMed ID: 11913726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single cell expression analysis--pharmacogenomic potential.
    Dixon AK; Lee K; Richardson PJ; Bell MI; Skynner MJ
    Pharmacogenomics; 2002 Nov; 3(6):809-22. PubMed ID: 12437482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacogenomics and pharmainformatics].
    Tanaka T; Nishimura Y; Tsunoda H; Kitaoka Y; Naka M
    Nihon Rinsho; 2002 Jan; 60(1):39-50. PubMed ID: 11808338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transcriptome analysis and pharmacogenomics].
    Tanaka T
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):241-6. PubMed ID: 11084921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacogenomics: the frontiers of genome medicine].
    Tanaka T; Tsujimoto G; Sugiyama Y; Hashimoto Y
    Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):141-8. PubMed ID: 12271509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNAi-based functional pharmacogenomics.
    Tuzmen S; Tuzmen P; Arora S; Mousses S; Azorsa D
    Methods Mol Biol; 2011; 700():271-90. PubMed ID: 21204040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic gene clusters as drug action mechanisms].
    Tanaka T
    Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():5P-7P. PubMed ID: 14727507
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.